BWXCD - METHOTREXATE SODIUM INJECTION, USP
- MSDS: BWXCD
- Manufacturer: FUJISAWA INC (FORMERLY LYPHOMED INC)
- Product Name: METHOTREXATE SODIUM INJECTION, USP
- National Stock Number: 6505-00F039484
Product Identification
Product ID:METHOTREXATE SODIUM INJECTION, USP
MSDS Date:02/17/1988
FSC:6505
NIIN:00F039484
Kit Part:Y
MSDS Number: BWXCD
Responsible Party
MELROSE PARK, IL 60160-5000
US
Emergency Phone: 708-450-7569/7500
Info Phone: 708-450-7569/7500
Cage: GO395
Contractor
Telephone: 312-345-6170
Cage: 60567
Ingredients
METHOTREXATE (IARC - GROUP 3) *95-1*
CAS: 59-05-2
RTECS: MA1225000
Hazards
LD50 LC50 Mixture:ORAL LD50 (RAT): 135 MG/KG
Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:POISONOUS BY SKIN CONTACT/INHALATION &
SWALLOWING. POSSIBLE ALLERGIC REACTION TO POWDER IF
INHALED/INGESTED/SKIN CONTACT. EYES/SKIN/RESPIRATORY TRACT
IRRITANT. SIGNS OF TOXICITY: ULCERATION OF THE MOU TH,
THROBOCYTOPENIA/ANEMIA/BONE MARROW DEPRESSION/LIVER/KIDNEY
DAMAGE/GI ULCERATION/PULMONARY/NEUROTOXIC (SEE SUPP).
Explanation of Carcinogenicity:NONE
Effects of Overexposure:IRRITATION, NAUSEA, VOMITING, DIARRHEA,
ALOPECIA, SKIN RASH.
First Aid
First Aid:INHALATION: REMOVE TO FRESH AIR. INGESTION: FLUSH MOUTH OUT
W/WATER. SKIN: FLUSH AREA W/WATER. EYES: FLUSH W/WATER. OBTAIN
MEDICAL ATTENTION IN ALL CASES.
Fire Fighting
Extinguishing Media:CO2, DRY CHEMICAL, FOAM AS APPROPRIATE FOR
SURROUNDING FIRES.
Fire Fighting Procedures:USE SELF CONTAINED BREATHING APPARATUS &
PROTECTIVE CLOTHING.
Unusual Fire/Explosion Hazard:DRY POWDER IS ASSUMED TO BE COMBUSTIBLE.
IT'S ADVISABLE TO GROUND MECHANICAL EQUIPMENT TO DISSIPATE BUILDUP
OF STATIC ELECTRICITY.
Accidental Release
Spill Release Procedures:WEAR RECOMMENDED PERSONAL PROTECTIVE
EQUIPMENT. VACUUM W/A VACUUM CLEANER HAVING A HIGH EFFICIENCY
PARTICULATE (HEPA) FILTER/ABSORB LIQUID W/PAPER TOWELS. WIPE
WORKING SURFACES TO DRYNESS, THEN WASH W /SOAP & WATER.
Handling
Handling and Storage Precautions:STORE IN A TIGHTLY CLOSED CONTAINERS
IN A COOL AREA. AVOID ALL FORMS OF UNPROTECTED CONTACT.
Exposure Controls
Respiratory Protection:NIOSH APPROVED RESPIRATOR
Ventilation:LOCAL EXHAUST RECOMMENDED
Protective Gloves:DISPOSABLE SURGICAL LATEX
Eye Protection:SAFETY GOGGLES
Other Protective Equipment:DISPOSABLE PROTECTIVE APPAREL.
Work Hygienic Practices:REMOVE/LAUNDER CONTAMINATED CLOTHING BEFORE
REUSE.
Supplemental Safety and Health
METHOTREXATE SODIUM FOR INJECTION, IS STERILE NONPYROGENIC, ISOTONIC,
SOLUTION OF METHOTREXATE PREPARED AS SODIUM SALT. HELATH HAZARDS
CONT'D: SUPPRESSION OF OVARIAN/TESTICULAR FUNCTION. NEUROTOXIC RE
ACTIONS ARE ASSOCIATED W/INTRATHECAL USE OF METHOTREXATE.
EYES/SKIN/RESPIRATORY TRACT: IRRITANT.
Chemical Properties
Appearance and Odor:YELLOW TO ORANGE LYOPHILIZED POWDER.
Stability
Stability Indicator/Materials to Avoid:YES
Stability Condition to Avoid:LIGHT
Hazardous Decomposition Products:TOXIC FUMES WHEN HEATED TO
DECOMPOSITION.
Disposal
Waste Disposal Methods:PLACE DRUG-SOLID ABSORBENTS INTO A LEAK-PROOF
CONTAINER & LABEL PROPERLY. THOUGH NOT EPA REGULATED, WASTE SHOULD
BE DISPOSED OF IAW/FEDERAL, STATE & LOCAL REGULATIONS.
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.